Skip to main content

Webinar: (2022-03) New Guidelines for Human Stem Cell-Related Research: Implications for IRBs and Institutions

Thank you

This live web event has ended. Thank you for attending.

Description

There have been stunning scientific advances in human stem cell-related research that abut an array of ethical and regulatory issues. To help address these issues at a practical level, the International Society for Stem Cell Research (ISSCR) updated its guidelines, which were released in May 2021. This session, which includes bioethics members of the global task force that updated the guidelines, will guide attendees through important IRB-specific aspects of the revised ISSCR guidelines. Speakers will provide an overview of the guidelines and discuss areas of human stem cell-related research that merit IRB review, including the procurement of biospecimens used to derive new stem cell lines, unique considerations for clinical translational research, and the differences between IRB review and the ISSCR’s specialized oversight system for stem cell research.

This webinar is based on a session the speakers presented at the 2021 AER Conference.

Agenda

  • The Development of Guidelines for Human Stem Cell Research/Overview of New Guidelines
  • Laboratory Based Research, Specialized Oversight Processes and the Procurement of Biospecimens 
  • Guidelines for Clinical Translation
  • Q&A
What will I learn?
  • Discuss the relationship of the ISSCR Guidelines to existing mechanisms of ethics oversight such as IRBs.
  • Understand the special considerations for IRB review for stem cell related research (such as that involving biospecimens and clinical translation).
  • Identify research that warrants specialized oversight that falls outside the remit of IRBs.
Who should attend?
IRB members, chairs and staff; Institutional Officials: researchers; IACUC and ESCRO members, chairs and staff. No prerequisite knowledge is required.

New discounts available for groups of various sizes from a single location!

Buy 4 get 1 free
Buy 12 get 6 free

For groups of 40 or more, please contact onlinelearning@primr.org to discuss special discount options.

To receive complimentary registrations, first register the paid registrants (e.g. if you’re using the buy 4 get 1 free discount, register the 4 paid individuals first) and then email onlinelearning@primr.org with a list of those paid individuals, as well as the name(s) and emails of those to receive complimentary registration.

Group discount requests must be received at least 24 hours before the event broadcast begins. Refunds or retroactive discounts are not available.

Access Interval
Access to live content will be available for 90 days after the recording is made available. After 90 days, access to the content will be removed, but users will retain access to any certificates of attendance earned. To earn a certificate, one must complete all required sections and complete the certificate section within the 90-day access period. After access has expired, users can purchase an additional 90 days of access.

If you prefer, you can find a paper registration form here. Please send the completed form to registration@primr.org

Continuing Education
Webinar participants holding the Certified IRB Professional (CIP®) credential may apply 1.25 continuing education credits towards CIP recertification. Learn More

Thank you to our sponsor!

WCG IRB provides the highest quality ethical reviews of clinical research protocols and studies.

*Please note that you cannot purchase this webinar on behalf of others. If you would like to register a colleague or a group, please fill out the paper form or contact onlinelearning@primr.org for an invoice.

Contributors

  • Insoo Hyun, PhD

    Insoo Hyun is Director of Research Ethics and a faculty member of the Center for Bioethics and senior lecturer on Global Health and Social Medicine at Harvard Medical School. He is also Professor of Bioethics and Philosophy at Case Western Reserve University School of Medicine. As a Fulbright Scholar and Hastings Center Fellow, Dr. Hyun's interests include ethical and policy issues in stem cell research and new biotechnologies.

    Dr. Hyun has been involved for many years with the ISSCR (International Society for Stem Cell Research). He has helped draft all of the ISSCR’s international research guidelines and is the current Chair of the ISSCR Ethics Committee.

    Dr. Hyun received his BA and MA in Philosophy with Honors in Ethics in Society from Stanford University and his PhD in Philosophy from Brown University. He has been interviewed frequently on National Public Radio and has served on national commissions for the Institute of Medicine and the National Academy of Sciences in Washington D.C. Dr. Hyun is a regular contributor to Nature, Science, Cell Stem Cell, The Hastings Center Report, among many other journals.

  • Rosario Isasi, JD, MPH

    Rosario Isasi, J.D., M.P.H., is a Research Associate Professor of Human Genetics at the Dr. John T. Macdonald Foundation Department of Human Genetics at the University of Miami Miller School of Medicine (MSOM). She holds multiple appointments including, as Adjunct Professor of Law at UM School of Law and as member of the John P. Hussman Institute for Human Genomics and the Interdisciplinary Stem Cell Institute at the MSOM.

    Prof. Isasi’s research is devoted to identifying and analyzing the social, ethical and policy dimensions of novel and disruptive genetic technologies, such as gene editing and synthetic biology. She has built an international reputation as a scholar with particular expertise in the area of international comparative law and ethics regarding genomics and regenerative medicine.

    She holds many leadership roles in major international initiatives. From 2017-2020, Prof. Isasi was appointed as the President’s International Fellow of the Chinese Academy of Sciences (CAS) and is currently an Adjunct Professor at the CAS’ Institute of Zoology. She is a co-Principal Investigator and Ethics/Regulatory lead for the South East Enrollment Center a consortium member of NIH’s All of Us Research Program. At the All of Us she is the co-Chair of their Committee on Access, Privacy and Policy and Security (CAPS). In addition, she serves as the Ethics/Policy Advisor of the European Commission’s European Human Pluripotent Stem Cell Registry (hPSCREG), as a member of the Advisory Board of the ASHG’s Human Genetics Scholars Initiative, the Diversity, Equity, & Inclusion Task Force and the Professional Practice & Social Implications Committee as well as of the Ethics & Policy Committee and Guidelines Task Force of the International Society for Stem Cell Research (ISSCR).

  • Jeremy Sugarman, MD, MPH, MA

    Johns Hopkins University
    Baltimore, MD

March 15, 2022
Tue 1:00 PM EDT

Duration 1H 15M

This live web event has ended.

Support Contact